The prospect of using the antioxidant dipeptide carnosine for the treatment of urate nephrolithiasis was evaluated. Urate nephrolithiasis was modeled in rats by intragastric administration of a mixture of oxonic and uric acids. Carnosine was administered intragastrically through a tube in a dose of 15 mg/kg. In rats treated with carnosine, the concentration of TBA-reactive products decreased by 1.4 times, the total antioxidant activity increased by 1.4 times, and catalase activity increased by 1.3 times. By the end of the experiment, the lactate dehydrogenate level in experimental rats was 2-fold lower than in the control, and the number of urate deposits decreased by 1.6 times with a concomitant alleviation of the inflammatory processes. Thus, the use of direct peptide antioxidant carnosine attenuated the manifestations of urate nephrolithiasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kaprin AD, Kostin AA, Ivanenko KV, Popov SV. Current studies of the efficacy of citrate therapy for uric acid nephrolithiasis in Russia. Med. Sovet. 2017;(11):176-180. Russian.
Methods of Preclinical (Experimental) Study of the Effect of Drugs on the Kidney Function. Novosibirsk, 2013. Russian.
Perfilev VYu, Zharikov AYu, Lykiyanenko DYu, Lysenko IV. The activity of free radical oxidation in the blood of rats against the background of experimental urate nephropathy. Med. Akad. Zh. 2016;16(4):188-189. Russian.
Perfilev VYu, Zverev YaF, Zharikov AYu. Conditions of urate nephrolithiasis and approaches to its modeling. Nefrologiya. 2017;21(4):48-54. Russian.
Khafizyanova RKh, Burikin IM, Aleeva GN. Mathematical Statistics in Experimental and Clinical Pharmacology. Kazan, 2006. Russian.
Alelign T, Petros B. Kidney Stone Disease: An Update on Current Concepts. Adv. Urol. 2018;2018:3068365. doi: https://doi.org/10.1155/2018/3068365
Kabakov AE, Gabai VL. Cell Death and Survival Assays. Methods Mol. Biol. 2018;1709:107-127. doi: https://doi.org/10.1007/978-1-4939-7477-1_9
Khan SR. Stress oxidative: nephrolithiasis and chronic kidney diseases. Minerva Med. 2013;104(1):23-30.
Peters V, Yard B, Schmitt C.P. Carnosine and Diabetic Nephropathy. Curr. Med. Chem. 2020;27(11):1801-1812. doi: https://doi.org/10.2174/0929867326666190326111851
Sakhaee K. Epidemiology and clinical pathophysiology of uric acid kidney stones. J. Nephrol. 2014;27(3):241-245. doi: https://doi.org/10.1007/s40620-013-0034-z
Song L, Maalouf NM. Nephrolithiasis. Endotext. MDText.com, Inc, 2000-[...]. URL: https://www.ncbi.nlm.nih.gov/books/NBK279069/
Spatola L, Ferraro PM, Gambaro G, Badalamenti S, Dauriz M. Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus. Metabolism. 2018;83:225-233. doi: https://doi.org/10.1016/j.metabol.2018.02.008
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 2, pp. 182-185, February, 2021
Rights and permissions
About this article
Cite this article
Kalnitsky, A.S., Zharikov, A.Y., Mazko, O.N. et al. Effect of Carnosine on the Course of Experimental Urate Nephrolithiasis. Bull Exp Biol Med 171, 218–221 (2021). https://doi.org/10.1007/s10517-021-05198-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05198-0